LFAS CLINICAL TRIALS AUTHORISATION SPECIALIST LTD
Summary
LFAS CLINICAL TRIALS AUTHORISATION SPECIALIST LTD was set up on Tuesday, May 17, 2016. Their current partial address is 107 SHERINGHAM AVENUE and the company status is Active - Proposal to Strike off.
Credit Score
Latest Accounts Filed:
31/07/2022
Next Set of Accounts Due:
30/04/2024
Company Vitals
Company Name:
LFAS CLINICAL TRIALS AUTHORISATION SPECIALIST LTD
Time in Business:
8 years
Company Number:
10184956
Current Status:
Active - Proposal to Strike off
Company Category:
Private Limited Company
Country of Origin:
United Kingdom
Principal Activity:
[72110] - Research and experimental development on biotechnology
Registered Address:
107 SHERINGHAM AVENUE
LONDON
ENGLAND
N14 4UJ
Filing History
Submission | Date | Type |
---|---|---|
Gazette dissolved voluntary | 2024-09-10 | GAZ2(A) |
Gazette notice voluntary | 2024-06-25 | GAZ1(A) |
Dissolution application strike off company | 2024-06-18 | DS01 |
Confirmation statement with no updates | 2023-06-15 | CS01 |
Accounts with accounts type total exemption full | 2023-03-31 | AA |
Confirmation statement with no updates | 2022-06-24 | CS01 |
Accounts with accounts type total exemption full | 2021-09-30 | AA |
Change account reference date company previous shortened | 2021-09-30 | AA01 |
Accounts with accounts type total exemption full | 2021-07-20 | AA |
Confirmation statement with no updates | 2021-06-25 | CS01 |
Accounts with accounts type total exemption full | 2020-12-08 | AA |
Confirmation statement with no updates | 2020-06-04 | CS01 |
Accounts with accounts type total exemption full | 2020-02-29 | AA |
Confirmation statement with no updates | 2019-05-31 | CS01 |
Accounts with accounts type total exemption full | 2019-02-28 | AA |
Accounts with accounts type total exemption full | 2018-06-20 | AA |
Confirmation statement with updates | 2018-06-14 | CS01 |
Change registered office address company with date old address new address | 2018-06-14 | AD01 |
Gazette filings brought up to date | 2017-10-14 | DISS40 |
Confirmation statement with updates | 2017-10-11 | CS01 |